Sep 26, 2024 · Nexlizet (bempedoic acid and ezetimibe) was approved by the FDA in February 2020 to help lower LDL (“bad”) cholesterol in adults, alongside diet. It can be used

Apr 4, 2025 · Nexlizet is a brand-name oral tablet prescribed to lower cholesterol in adults. Nexlizet contains two active ingredients: bempedoic acid and ezetimibe. It belongs to

Jun 30, 2024 · Nexlizet reduces cholesterol by decreasing the amount made by your liver and increasing the breakdown of bad cholesterol. It also inhibits the absorption of cholest

NEXLIZET and NEXLETOL are the only oral nonstatins FDA approved to lower bad cholesterol and reduce the risk* of the first or next serious heart event † in patients with statin i

Nov 18, 2025 · Nexlizet Patient Tips Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 18, 2025. How it works Upsides Downsides Bottom Line Tips Response/effectivenes

May 27, 2025 · Nexlizet (bempedoic acid/ezetimibe) is a prescription tablet used to help lower cholesterol and reduce the risk of heart attack as well as heart surgery. Nexlizet i

bempedoic acid, a component of NEXLIZET and NEXLETOL, is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, myocardial infarction, stroke, o

Apr 10, 2024 · What Is Nexlizet? Nexlizet (bempedoic acid and ezetimibe) contains an adenosine triphosphate-citrate lyase (ACL) inhibitor and a cholesterol absorption inhibitor an

Mar 3, 2020 · The FDA has approved two new non-statin drugs that clinical trials indicated can help reduce high cholesterol. Nexletol and Nexlizet can be used with statins that ha

Aug 29, 2025 · Patient assistance programs and discount copay cards are available for eligible patients 1 By following this evidence-based approach to using Nexlizet, clinicians c